153 results
SD
EX-1.01
ABBV
Abbvie Inc
31 May 24
Conflict minerals disclosure
4:05pm
people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases
424B5
ABBV
Abbvie Inc
26 Feb 24
Prospectus supplement for primary offering
6:12am
to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases.
AbbVie’s products … , aesthetics and eye care. AbbVie uses its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies
424B5
8jbna5398
21 Feb 24
Prospectus supplement for primary offering
8:39am
8-K
EX-99.1
chqd250r0giuya7
6 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
5:28pm
8-K
EX-99.1
8mo8bvzfd
30 Nov 23
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
8:47am
PX14A6G
udo5mc3
4 May 23
Letter to shareholders
8:08am
8-K
9ym4ao8zytwi5m
13 Apr 22
Departure of Directors or Certain Officers
9:15am
PX14A6G
zxs5qr56oa4rkaeseuu
11 Apr 22
Letter to shareholders
4:35pm